Emami Ltd (EMAMILTD) Q2FY26 Concall Summary - Sep-2025 Qtr
Performance Overview
- The company's performance was significantly impacted by a government-led GST rate reduction, which caused temporary trade disruptions and purchase deferrals, leading to a consolidated revenue decline.
- The summer portfolio, particularly talc and prickly heat powders, faced a second consecutive challenging quarter due to heavy rains and a high base from the previous year, contributing to the sales decline.
- Despite the overall downturn, the international business demonstrated resilience with steady growth, and certain non-GST impacted domestic portfolios like the Medico range, Zandu cough syrup, and Honey delivered encouraging growth.
- The company's strategic investment portfolios, including brands like Brillare and The Man Company (TMC), showed a strong rebound with significant year-on-year and sequential growth, driven by increased investments and channel gains.
- Management expressed strong optimism for a robust recovery in the second half of the fiscal year, citing a healthy rebound in October, recovery of deferred winter product loading, and the normalization of trade channels post-GST reform.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.